Nexgel, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
NXGL
Nexgel, INCNexGel, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding executive compensation, governance, and board composition.
NASDAQ
NXGL
Nexgel, INCNexGel, Inc. reported a 31.5% increase in net revenues to $11.421 million for the fiscal year ended December 31, 2025, driven by consumer product sales, but continues to face substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows.
NASDAQ
NXGL
Nexgel, INC10-K: NexGel, Inc. Reports Significant Revenue Growth in 2024 Driven by Consumer Product Acquisitions
NexGel, Inc. announces a substantial 112.5% increase in revenue for 2024, primarily driven by growth in branded consumer products and strategic acquisitions.
NASDAQ
NXGL
Nexgel, INC10-K/A: NexGel Inc. Files Amendment to 2023 Annual Report to Include Management's Internal Control Report
NexGel Inc. has filed an amendment to its 2023 annual report to include management's report on internal control over financial reporting, which was inadvertently omitted from the original filing.
NASDAQ
NXGL
Nexgel, INCNexGel Inc.'s 2023 annual report reveals significant revenue growth, strategic acquisitions, and ongoing development in medical devices and consumer products.